Evolus, Inc. (EOLS)
NASDAQ: EOLS · IEX Real-Time Price · USD
11.85
-0.11 (-0.92%)
Jul 22, 2024, 10:16 AM EDT - Market open
Evolus Employees
Evolus had 273 employees as of December 31, 2023. The number of employees increased by 58 or 26.98% compared to the previous year.
Employees
273
Change (1Y)
58
Growth (1Y)
26.98%
Revenue / Employee
$804,751
Profits / Employee
-$219,791
Market Cap
750.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Embecta | 2,200 |
| Phibro Animal Health | 1,920 |
| Sage Therapeutics | 487 |
| Travere Therapeutics | 380 |
| OrthoPediatrics | 247 |
| Pliant Therapeutics | 158 |
| 4D Molecular Therapeutics | 147 |
| Dianthus Therapeutics | 53 |
EOLS News
- 5 days ago - Evolus to Report Second Quarter Financial Results on July 31, 2024 - Business Wire
- 21 days ago - Evolus Announces Appointment of Albert G. White III to Board of Directors - Business Wire
- 4 weeks ago - Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products - Business Wire
- 5 weeks ago - Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain - Business Wire
- 6 weeks ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting - Business Wire
- 2 months ago - Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women's Wear Daily Beauty CEO Summit - Business Wire
- 2 months ago - Evolus' Sandra Beaver Named Orange County Business Journal's Public Company CFO of the Year - Business Wire